Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial

Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease

(2014) Thet Thet Lin et al.   BRITISH JOURNAL OF HAEMATOLOGY

ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial

(2014) M. J. J. Rose-Zerilli et al.   HAEMATOLOGICA

Short telomere length is associated withNOTCH1/SF3B1/TP53aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients

(2013) Larry Mansouri et al.   AMERICAN JOURNAL OF HEMATOLOGY

Telomere dysfunction and its role in haematological cancer

(2012) Ceri H. Jones et al.   BRITISH JOURNAL OF HAEMATOLOGY

Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial

(2012) Anna Skowronska et al.   JOURNAL OF CLINICAL ONCOLOGY

Telomeres and prognosis in patients with chronic lymphocytic leukaemia

(2011) Ludger Sellmann et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Mutational Status of theTP53Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial

(2011) David Gonzalez et al.   JOURNAL OF CLINICAL ONCOLOGY

Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis

(2010) T. T. Lin et al.   BLOOD

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation

(2010) D. Oscier et al.   HAEMATOLOGICA

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia

(2009) D Rossi et al.   LEUKEMIA